Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,748 | -66,339 | -14,892 | -51,314 | -23,955 |
| Depreciation Amortization | 1,743 | 4,429 | 3,374 | 2,378 | 1,187 |
| Accounts receivable | -2,975 | -7,807 | -3,564 | -732 | -2,258 |
| Accounts payable and accrued liabilities | -851 | 2,232 | -7,234 | -4,864 | -3,715 |
| Other Working Capital | -672 | -5,324 | -7,306 | -5,847 | -9,494 |
| Other Operating Activity | 2,231 | 33,517 | 19,525 | 14,290 | 6,501 |
| Operating Cash Flow | $-26,272 | $-39,291 | $-10,096 | $-46,089 | $-31,734 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,356 | 49,457 | 32,127 | -14,753 | 7,375 |
| PPE Investments | -274 | -2,117 | -887 | -685 | -442 |
| Purchase Of Investment | N/A | -433,214 | -328,940 | N/A | N/A |
| Sale Of Investment | 28,381 | 177,127 | 151,143 | N/A | 36,876 |
| Purchase Sale Intangibles | -85 | -761 | -577 | -246 | -54 |
| Other Investing Activity | -5,750 | -600 | -493 | -176,584 | -35,641 |
| Investing Cash Flow | $30,713 | $-209,347 | $-147,050 | $-192,021 | $8,168 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,206 | 1,187 | 37 | N/A |
| Common Stock Issued | N/A | 228,658 | 225,115 | 230,904 | N/A |
| Other Financing Activity | -972 | -17,919 | -17,488 | -17,936 | 0 |
| Financing Cash Flow | $-972 | $211,945 | $208,813 | $213,005 | $N/A |
| Exchange Rate Effect | 7 | -70 | -61 | N/A | N/A |
| Beginning Cash Position | 51,633 | 90,452 | 89,050 | 91,340 | 94,143 |
| End Cash Position | 55,109 | 53,688 | 140,657 | 66,235 | 70,578 |
| Net Cash Flow | $3,476 | $-36,764 | $51,607 | $-25,105 | $-23,566 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,272 | -39,291 | -10,096 | -46,089 | -31,734 |
| Capital Expenditure | -274 | -2,150 | -920 | -713 | -471 |
| Free Cash Flow | -26,546 | -41,442 | -11,016 | -46,802 | -32,204 |